Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Effects of Osteochondrin S and select connective tissue ribonucleinate components on human osteoclasts in vitro.

Cantley MD, Rainsford KD, Haynes DR.

J Pharm Pharmacol. 2013 Aug;65(8):1214-22. doi: 10.1111/jphp.12088.

PMID:
23837589
2.

Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro.

Cantley MD, Fairlie DP, Bartold PM, Rainsford KD, Le GT, Lucke AJ, Holding CA, Haynes DR.

J Cell Physiol. 2011 Dec;226(12):3233-41. doi: 10.1002/jcp.22684.

PMID:
21344383
3.

Azithromycin suppresses human osteoclast formation and activity in vitro.

Gannon SC, Cantley MD, Haynes DR, Hirsch R, Bartold PM.

J Cell Physiol. 2013 May;228(5):1098-107. doi: 10.1002/jcp.24259.

PMID:
23065774
4.

Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation.

Zawawi MS, Dharmapatni AA, Cantley MD, McHugh KP, Haynes DR, Crotti TN.

Biochem Biophys Res Commun. 2012 Oct 19;427(2):404-9. doi: 10.1016/j.bbrc.2012.09.077.

PMID:
23000414
5.

BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.

Valverde P, Tu Q, Chen J.

J Bone Miner Res. 2005 Sep;20(9):1669-79.

6.

Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages.

Rahman MM, Kukita A, Kukita T, Shobuike T, Nakamura T, Kohashi O.

Blood. 2003 May 1;101(9):3451-9.

7.

Retinoic acid increases proliferation of human osteoclast progenitors and inhibits RANKL-stimulated osteoclast differentiation by suppressing RANK.

Hu L, Lind T, Sundqvist A, Jacobson A, Melhus H.

PLoS One. 2010 Oct 11;5(10):e13305. doi: 10.1371/journal.pone.0013305.

8.

Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.

Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeichi O, Tsuzukibashi O, Makimura M, Ito K, Maeno M.

Life Sci. 2007 Mar 13;80(14):1311-8.

PMID:
17306833
10.

Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells.

Lee JW, Iwahashi A, Hasegawa S, Yonezawa T, Jeon WB, Cha BY, Nagai K, Woo JT.

J Nat Med. 2012 Jan;66(1):8-16. doi: 10.1007/s11418-011-0537-7.

PMID:
21656335
11.
12.

Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption.

Ha H, Shim KS, An H, Kim T, Ma JY.

BMC Complement Altern Med. 2013 May 21;13:112. doi: 10.1186/1472-6882-13-112.

14.

Gene array identification of osteoclast genes: differential inhibition of osteoclastogenesis by cyclosporin A and granulocyte macrophage colony stimulating factor.

Day CJ, Kim MS, Stephens SR, Simcock WE, Aitken CJ, Nicholson GC, Morrison NA.

J Cell Biochem. 2004 Feb 1;91(2):303-15.

PMID:
14743390
15.

Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.

Kanatani M, Sugimoto T, Kano J, Kanzawa M, Chihara K.

J Cell Physiol. 2003 Jul;196(1):180-9.

PMID:
12767054
16.

Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signaling.

Strålberg F, Henning P, Gjertsson I, Kindlund B, Souza PP, Persson E, Abrahamson M, Kasprzykowski F, Grubb A, Lerner UH.

FASEB J. 2013 Jul;27(7):2687-701. doi: 10.1096/fj.12-211748.

19.
20.

Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.

Shalhoub V, Faust J, Boyle WJ, Dunstan CR, Kelley M, Kaufman S, Scully S, Van G, Lacey DL.

J Cell Biochem. 1999 Feb 1;72(2):251-61.

PMID:
10022507
Items per page

Supplemental Content

Support Center